blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2566843

EP2566843 - PROCESS FOR THE PREPARATION OF CHIRAL BETA AMINO CARBOXAMIDE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.02.2018
Database last updated on 12.11.2024
FormerThe patent has been granted
Status updated on  24.02.2017
FormerGrant of patent is intended
Status updated on  29.01.2017
FormerExamination is in progress
Status updated on  31.10.2016
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Sun Pharmaceutical Industries Limited
17/B, Mahal Industrial Estate
Off Mahakali Caves Road
Andheri (East)
Mumbai 400 093 / IN
[2013/11]
Inventor(s)01 / JADAV, Kanaksinh Jesingbhai
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
02 / BHATT, Rutvij Manharlal
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
03 / BORKHATARIA, Kamleshkumar Naranbhai
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
04 / CHITTURI, Trinadha Rao
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
05 / THENNATI, Rajamannar
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
 [2017/09]
Former [2013/11]01 / JADAV, Kanaksinh Jesingbhai
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
02 / BHATT, RutvijManharlal
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
03 / BORKHATARIA, Kamleshkumar Naranbhai
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
04 / CHITTURI, Trinadha Rao
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
05 / THENNATI, Rajamannar
Sun Pharma Advanced Research Centre
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390 020 / IN
Representative(s)HGF
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2017/13]Atkinson, Jonathan David Mark, et al
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
Former [2013/30]Atkinson, Jonathan David Mark, et al
Harrison Goddard Foote LLP
Belgrave Hall
Belgrave Street
Leeds LS2 8DD / GB
Former [2013/11]Harrison Goddard Foote
Belgrave Hall
Belgrave Street
Leeds
LS2 8DD / GB
Application number, filing date11774543.028.04.2011
[2017/13]
WO2011IN00289
Priority number, dateIN2010MUM135828.04.2010         Original published format: IN MU13582010
[2013/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011135586
Date:03.11.2011
Language:EN
[2011/44]
Type: A2 Application without search report 
No.:EP2566843
Date:13.03.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 03.11.2011 takes the place of the publication of the European patent application.
[2013/11]
Type: B1 Patent specification 
No.:EP2566843
Date:29.03.2017
Language:EN
[2017/13]
Search report(s)International search report - published on:AT27.12.2012
(Supplementary) European search report - dispatched on:EP02.09.2013
ClassificationIPC:C07C231/02, C07D487/04
[2013/11]
CPC:
C07C229/34 (EP,US); C07C227/14 (EP,US); C07D487/04 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/11]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG CHIRALER BETA-AMINOCARBOXAMID-DERIVATE[2013/11]
English:PROCESS FOR THE PREPARATION OF CHIRAL BETA AMINO CARBOXAMIDE DERIVATIVES[2013/11]
French:PROCÉDÉ DE PRÉPARATION DE DÉRIVÉS CHIRAUX DE BÊTA-AMINO CARBOXAMIDE[2013/11]
Entry into regional phase23.10.2012National basic fee paid 
23.10.2012Search fee paid 
23.10.2012Designation fee(s) paid 
23.10.2012Examination fee paid 
Examination procedure23.10.2012Examination requested  [2013/11]
27.03.2014Amendment by applicant (claims and/or description)
31.10.2014Despatch of a communication from the examining division (Time limit: M04)
12.02.2015Reply to a communication from the examining division
19.05.2015Despatch of a communication from the examining division (Time limit: M04)
01.09.2015Reply to a communication from the examining division
05.11.2015Despatch of a communication from the examining division (Time limit: M04)
11.03.2016Reply to a communication from the examining division
05.07.2016Despatch of a communication from the examining division (Time limit: M04)
28.10.2016Reply to a communication from the examining division
30.01.2017Communication of intention to grant the patent
14.02.2017Fee for grant paid
14.02.2017Fee for publishing/printing paid
14.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.10.2014
Opposition(s)03.01.2018No opposition filed within time limit [2018/10]
Fees paidRenewal fee
26.03.2013Renewal fee patent year 03
22.04.2014Renewal fee patent year 04
02.02.2015Renewal fee patent year 05
27.04.2016Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.04.2011
AL29.03.2017
AT29.03.2017
CY29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
MK29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
TR29.03.2017
IE28.04.2017
LU28.04.2017
MT28.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
[2020/33]
Former [2020/15]HU28.04.2011
AT29.03.2017
CY29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
MK29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
TR29.03.2017
IE28.04.2017
LU28.04.2017
MT28.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2019/51]HU28.04.2011
AT29.03.2017
CY29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
MK29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
IE28.04.2017
LU28.04.2017
MT28.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2019/46]HU28.04.2011
AT29.03.2017
CY29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
IE28.04.2017
LU28.04.2017
MT28.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2019/31]HU28.04.2011
AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
IE28.04.2017
LU28.04.2017
MT28.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2018/43]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
IE28.04.2017
LU28.04.2017
MT28.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2018/23]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
IE28.04.2017
LU28.04.2017
BE30.04.2017
CH30.04.2017
LI30.04.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2018/13]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
SM29.03.2017
LU28.04.2017
CH30.04.2017
LI30.04.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2018/09]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2018/06]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2017/51]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2017/50]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
Former [2017/49]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
Former [2017/48]CZ29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
RS29.03.2017
SE29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
Former [2017/41]FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
RS29.03.2017
SE29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
Documents cited:Search[Y]WO03004498  (MERCK & CO INC [US], et al) [Y] 1-15* page 28; example 1 *;
 [Y]WO2009085990  (REDDYS LAB LTD DR [IN], et al) [Y] 1-15 * examples 7-9; claim 7 *
International search[A]WO2004085661  (MERCK & CO INC [US], et al);
 [A]WO2009085990  (REDDYS LAB LTD DR [IN], et al)
 [A]  - ANON., "A process for preparing (3R)-3-amino-1-[9-(trifluomethyl)-1, 4, 7, 8- tetrazabicyclo(4.3.0]nona-6,8-dien-4-yl]-4-(2,4,5-trifluorophenyl) -1 -butanone", IP.COM, (2009), vol. 9, no. 5B, page 36
by applicantWO03004498
 US6699871
 WO2004085661
 US2008058522
 WO2009085990
 US2009192326
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.